JP2011529868A - ３，４−ジアリール−４，５−ジヒドロ−（１ｈ）−ピラゾール−１−カルボキシアミジン誘導体の合成 - Google Patents

３，４−ジアリール−４，５−ジヒドロ−（１ｈ）−ピラゾール−１−カルボキシアミジン誘導体の合成 Download PDF

Info

Publication number
JP2011529868A
JP2011529868A JP2011520514A JP2011520514A JP2011529868A JP 2011529868 A JP2011529868 A JP 2011529868A JP 2011520514 A JP2011520514 A JP 2011520514A JP 2011520514 A JP2011520514 A JP 2011520514A JP 2011529868 A JP2011529868 A JP 2011529868A
Authority
JP
Japan
Prior art keywords
formula
alkyl
compound
independently
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011520514A
Other languages
English (en)
Japanese (ja)
Inventor
ランゲ，ジヨセフス・エイチ・エム
サンダース，ハンス・ジエイ
バン・レーネン，ジエロエン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Healthcare Products BV
Original Assignee
Abbott Healthcare Products BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products BV filed Critical Abbott Healthcare Products BV
Publication of JP2011529868A publication Critical patent/JP2011529868A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2011520514A 2008-08-01 2009-07-30 ３，４−ジアリール−４，５−ジヒドロ−（１ｈ）−ピラゾール−１−カルボキシアミジン誘導体の合成 Pending JP2011529868A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8547508P 2008-08-01 2008-08-01
EP08161619 2008-08-01
US61/085,475 2008-08-01
EP08161619.5 2008-08-01
PCT/EP2009/059844 WO2010012797A2 (en) 2008-08-01 2009-07-30 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives

Publications (1)

Publication Number Publication Date
JP2011529868A true JP2011529868A (ja) 2011-12-15

Family

ID=40380031

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011520514A Pending JP2011529868A (ja) 2008-08-01 2009-07-30 ３，４−ジアリール−４，５−ジヒドロ−（１ｈ）−ピラゾール−１−カルボキシアミジン誘導体の合成

Country Status (12)

Country Link
EP (1) EP2321280A2 (es)
JP (1) JP2011529868A (es)
KR (1) KR20110042095A (es)
CN (1) CN102089284A (es)
AR (1) AR072539A1 (es)
AU (1) AU2009275838A1 (es)
BR (1) BRPI0916692A2 (es)
CA (1) CA2729969A1 (es)
EA (1) EA201170284A1 (es)
MX (1) MX2011001211A (es)
TW (1) TW201010981A (es)
WO (1) WO2010012797A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079935A1 (es) * 2010-01-29 2012-02-29 Abbott Healthcare Products Bv Sintesis de derivados de pirazolin carboxamidina sustituida
US20220227714A1 (en) * 2019-05-17 2022-07-21 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services A scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase
CN111686806B (zh) * 2020-05-29 2022-09-30 黑龙江大学 一种聚[2-(3-噻吩基)乙醇]/石墨相氮化碳复合可见光催化剂的制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369121A (en) * 1990-01-31 1994-11-29 E. I. Du Pont De Nemours And Company Arthropodicidal pyrazolines, pyrazolidines and hydrazines
DE4005114A1 (de) * 1990-02-17 1991-08-22 Bayer Ag Substituierte pyrazolinderivate
ATE346047T1 (de) * 2000-03-23 2006-12-15 Solvay Pharm Bv 4,5-dihydro-1h-pyrazolderivate mit cb1- antagonistischer aktivität
UA77441C2 (en) * 2001-09-21 2006-12-15 4,5-dihydro-1h-pyrazole derivatives as potent cb1 receptor antagonists, methods for their preparation (variants), intermediate, pharmaceutical composition and method for its preparation

Also Published As

Publication number Publication date
EA201170284A1 (ru) 2011-06-30
WO2010012797A2 (en) 2010-02-04
EP2321280A2 (en) 2011-05-18
CN102089284A (zh) 2011-06-08
BRPI0916692A2 (pt) 2016-05-17
WO2010012797A3 (en) 2010-04-22
MX2011001211A (es) 2011-03-29
TW201010981A (en) 2010-03-16
AR072539A1 (es) 2010-09-01
AU2009275838A1 (en) 2010-02-04
KR20110042095A (ko) 2011-04-22
CA2729969A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
US6974810B2 (en) 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
CN105283442A (zh) 用于合成1-(2-((2,4-二甲基苯基）硫代）苯基）哌嗪的新方法
TWI283667B (en) Selective synthesis of CF3-substituted pyrimidines
EA018227B1 (ru) Способ получения дабигатрана и его промежуточные соединения
JP2020518661A (ja) ベンゾイミダゾール系化合物およびその製造方法
US20080058543A1 (en) Process for making chiral 1,4-disubstituted piperazines
JP2011529868A (ja) ３，４−ジアリール−４，５−ジヒドロ−（１ｈ）−ピラゾール−１−カルボキシアミジン誘導体の合成
EP1718636B1 (en) New compounds useful for the synthesis of s- and r-omeprazole and a process for their preparation
JP2010111684A (ja) キラル２−メチル−４−保護化ピペラジンの立体選択的アルキル化
WO1996029330A1 (fr) Derives de la thiazole
US20110137040A1 (en) Synthesis of 3,4-diaryl-4,5-dihydro-(h)-pyrazole-1-carboxamidine derivatives
EP1367052B1 (en) Intermediate for the preparation of carvedilol
JP5792195B2 (ja) 置換されたピラゾリンカルボキシアミジン誘導体の合成
KR101079065B1 (ko) 치환된 이미다졸 유도체를 제조하기 위한 방법 및 공정에서사용된 중간체
JP2012153674A (ja) ジ（アリールアミノ）アリール化合物の製造方法及びその合成中間体
WO2010064212A1 (en) Method for obtaining an optically pure 1,2,3,4 tetrahydro-isoquinoline derivative